Cargando…
Mesoporous Silica Modified with Polydopamine and Zinc Ions as a Potential Carrier in the Controlled Release of Mercaptopurine
Mercaptopurine is one of the drugs used in the treatment of acute lymphoblastic leukemia. A problem with mercaptopurine therapy is its low bioavailability. This problem can be solved by preparing the carrier that releases the drug in lower doses but over a longer period of time. In this work, polydo...
Autores principales: | Sandomierski, Mariusz, Chojnacka, Martyna, Długosz, Maria, Pokora, Monika, Zwolińska, Joanna, Majchrzycki, Łukasz, Voelkel, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301584/ https://www.ncbi.nlm.nih.gov/pubmed/37374542 http://dx.doi.org/10.3390/ma16124358 |
Ejemplares similares
-
Zeolites
with Divalent Ions as Carriers in the Delivery
of Epigallocatechin Gallate
por: Sandomierski, Mariusz, et al.
Publicado: (2023) -
Characterization of Magnesium and Zinc Forms of Sodalite Coatings on Ti6Al4V ELI for Potential Application in the Release of Drugs for Osteoporosis
por: Sandomierski, Mariusz, et al.
Publicado: (2023) -
Resveratrol Encapsulation and Release from Pristine and Functionalized Mesoporous Silica Carriers
por: Ioniţă, Simona, et al.
Publicado: (2022) -
Zeolitic Imidazolate Framework‑8 (ZIF-8) modified titanium alloy for controlled release of drugs for osteoporosis
por: Sandomierski, Mariusz, et al.
Publicado: (2022) -
Mesoporous Silica Nanoparticles as Carriers for Therapeutic Biomolecules
por: Castillo, Rafael R., et al.
Publicado: (2020)